| 12410170 |
2,3,5-trisubstituted pyrazolo[1,5-A]pyrimidine compounds |
Joel Worley Beatty, Samuel Lawrie Drew, Jeremy Thomas Andre Fournier, Jenna Leigh Jeffrey, Kenneth V. Lawson +7 more |
2025-09-09 |
| 12384773 |
Thiazole compounds and methods of use thereof |
Srijita Bhowmik, Karen Yir Jing Chen, Jenna Leigh Jeffrey, Manjunath Lamani, Guillaume Mata +7 more |
2025-08-12 |
| 12226425 |
Inhibitors of ARG1 and/or ARG2 |
Joel Worley Beatty, Eric Newcomb, Jay P. Powers, Brandon Reid Rosen, Yongli Su +8 more |
2025-02-18 |
| 12195447 |
Azolopyrimidine for the treatment of cancer-related disorders |
Joel Worley Beatty, Laurent P. Debien, Jenna Leigh Jeffrey, Debashis Mandal, Dillon Harding Miles +4 more |
2025-01-14 |
| 12195482 |
Compounds as inhibitors of AXL |
Joel Worley Beatty, Corinne Nicole Foley, Balint Gal, Manjunath Lamani, Dillon Harding Miles +3 more |
2025-01-14 |
| 12168023 |
Inhibitors of adenosine 5′-nucleotidase |
Laurent P. Debien, Jaroslaw Kalisiak, Kenneth V. Lawson, Erick Allen Lindsey, Dillon Harding Miles +4 more |
2024-12-17 |
| 12145901 |
Process for preparing tetralin compounds |
Joel Worley Beatty, Samuel Lawrie Drew, Matthew Epplin, Jeremy Thomas Andre Fournier, Balint Gal +9 more |
2024-11-19 |
| 12139475 |
2-oxindole compounds |
Xi Chen, Dean R. Dragoli, Pingchen Fan, Rebecca M. Lui, Viengkham Malathong +6 more |
2024-11-12 |
| 12103907 |
Tetralin and tetrahydroquinoline compounds as inhibitors of HIF-2alpha |
Joel Worley Beatty, Samuel Lawrie Drew, Matthew Epplin, Jeremy Thomas Andre Fournier, Balint Gal +19 more |
2024-10-01 |
| 12071411 |
Inhibitors of HIF-2α and methods of use thereof |
Joel Worley Beatty, Samuel Lawrie Drew, Matthew Epplin, Jeremy Thomas Andre Fournier, Balint Gal +9 more |
2024-08-27 |
| 12064433 |
Pyridone A2R antagonists |
Debashis Mandal, Dillon Harding Miles, Jay P. Powers, Brandon Reid Rosen, Ehesan Ul Sharif |
2024-08-20 |
| 11993584 |
Solid forms of an azolopyrimidine compound |
Jenna Leigh Jeffrey, Dillon Harding Miles, Jay P. Powers |
2024-05-28 |
| 11951214 |
Capsule formulations |
Jay P. Powers |
2024-04-09 |
| 11945805 |
Inhibitors of CXCR2 |
Xi Chen, Dean R. Dragoli, Junfa Fan, Jaroslaw Kalisiak, Viengkham Malathong +6 more |
2024-04-02 |
| 11931343 |
CD73 inhibitors |
Joel Worley Beatty, Laurent P. Debien, Samuel Lawrie Drew, Jeremy Thomas Andre Fournier, Rebecca Grange +9 more |
2024-03-19 |
| 11884654 |
Substituted anilines as CCR(4) antagonists |
Trevor T. Charvat, Junfa Fan, Christopher W. Lange, Yandong Li, Venkat Reddy Mali +4 more |
2024-01-30 |
| 11820759 |
Modulators of chemokine receptors |
Xi Chen, Dean R. Dragoli, Junfa Fan, Jaroslaw Kalisiak, Antoni Krasinski +7 more |
2023-11-21 |
| 11787762 |
Tetralin and tetrahydroquinoline compounds as inhibitors of HIF-2alpha |
Joel Worley Beatty, Samuel Lawrie Drew, Matthew Epplin, Jeremy Thomas Andre Fournier, Balint Gal +19 more |
2023-10-17 |
| 11667662 |
Modulators of 5′-nucleotidase, ecto and the use thereof |
Laurent P. Debien, Juan C. Jaen, Jaroslaw Kalisiak, Kenneth V. Lawson, Erick Allen Lindsey +5 more |
2023-06-06 |
| 11633416 |
Oral formulations of CD73 compounds |
Kenneth V. Lawson, Jay P. Powers |
2023-04-25 |
| 11603356 |
Amorphous form of a complement component C5a receptor |
Kwok YAU, Kenken Luong, Rajinder Singh, Yibin Zeng, Penglie Zhang +1 more |
2023-03-14 |
| 11434230 |
2-oxindole compounds |
Xi Chen, Dean R. Dragoli, Pingchen Fan, Rebecca M. Lui, Viengkham Malathong +6 more |
2022-09-06 |
| 11407712 |
Tetralin and tetrahydroquinoline compounds as inhibitors of HIF-2α |
Joel Worley Beatty, Samuel Lawrie Drew, Matthew Epplin, Jeremy Thomas Andre Fournier, Balint Gal +19 more |
2022-08-09 |
| 11267845 |
Inhibitors of CD73-mediated immunosuppression |
Jaroslaw Kalisiak, Kenneth V. Lawson, Erick Allen Lindsey, Dillon Harding Miles, Eric Newcomb +2 more |
2022-03-08 |
| 11220492 |
Quinazoline-pyrazole derivatives for the treatment of cancer-related disorders |
Dillon Harding Miles, Jay P. Powers, Brandon Reid Rosen, Ehesan Ul Sharif |
2022-01-11 |